Objective
=========

To evaluate the potential clinical utility of T2 quantitative mapping for myocardial edema in acute disease pathology - myocarditis, myocardial infarction, Tako-Tsubo cardiomyopathy, and transplant rejection.

Background
==========

Edema is a generic tissue response to acute myocardial injury and, therefore; a potential marker of impending tissue damage. Currently in clinical use, T2 weighted imaging provides a qualitative technique in assessing myocardial edema. We hypothesize that quantitative T2 mapping in patients with suspected cases of myocarditis, myocardial infarction (AMI), and cardiac transplant rejection will provide a more sensitive and specific diagnostic prediction than with T2W imaging, and add to other imaging techniques.

Method
======

We used a non-contrast multiplanar single-shot and cine TrueFISP and steady state free precession (SSFP) sequence developed by Siemens Healthcare which consists of T2-prepared, linear flip angle series of 20, 60, and 90 degrees, and SSFP readout. ECG triggered breathold T2 mapping was done on the three short axis and 4 chamber images on a 1.5 T scanner (MAGNETOM Avanto, Siemens Erlangen, Germany). Regions of interest (ROI) based on the 17 segment myocardial model were drawn by two blinded reviewers (AU and MW) for inter-rater and intra-rater reliability.

Results
=======

Complete results are presented in table [1](#T1){ref-type="table"}. T2 mapping was done on 6 suspected acute myocarditis, 13 AMI, 1 Tako-Tsubo cardiomyopathy, and 25 transplant patients. The average age of all patients was 50.9 ± 7.8 years old, 62% male, and average scan time was 45 minutes. Control studies on normal patients demonstrated a global T2 mapping average of 51.2 ± 2.7 ms. Of the 6 patients with suspected myocarditis 3 were found to have no myocarditis based on MR criteria and clinical follow-up (100% concordance with T2 mapping). The 3 patients with myocarditis had cardiac sarcoidosis, viral, and giant cell myocarditis with average T2 of 70.6 ± 6.7 ms (p\<0.05). 10/12 suspected AMI patients had segmentally concordant T2 values in relation to delayed enhancement outcomes. The average infract segment T2 value was 66.4 ± 3.2 ms (p\<0.05). The basal T2 value in the Tako-Tsubo case was 52.3 ± 3.2 ms, while the mid and apical average were 68.0 ± 4.2 ms (p\<0.05). Figure [1](#F1){ref-type="fig"}

###### 

Demographics

  Total cases                   65                                                     
  ----------------------------- ------------ ------------- ------------- ------------- ----------------
  Group                         Controls     Transplant    AMI           Myocarditis   Cardiomyopathy
                                                                                       
  Average age                   32.7 ± 7.3   55.8 ± 13.8   55.5 ± 10.3   49.2 ± 13.2   60
  Percent female                50%          44%           33%           33%           100%
  Normal\*\*                    20           22            4             3             0
  Disease                       NA           3             8             3             1
  Total                         20           25            12            6             1
  Outcomes                                                                             
  Average T2 Normal ROI (ms)    51.2 ± 2.7   52.1 ± 2.4    54.1 ± 3.1    54.0 ± 3.7    52.3 ± 3.1
  Average T2 Disease ROI (ms)   NA           61.6 ± 3.1    65.0 ± 4.4    67.1 ± 7.5    68.0 ± 4.2
  Significance                  NA           \<0.05        \<0.05        \<0.05        \<0.05\*
  Ejection fraction             62%          58.7%         39.\$%        41/1%         32.2%

\*p-value compared internally from basal segment to mid and apical segment

\*\* Normal represents cases that were suspected to have outcome, i.e. AMI, myocarditis, etc, but were by clinical assessment MRI, and cellular pathology determined not to have any disease. These cases T2 Mapping were compared to cases with in-group pathology.
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Conclusions
===========

T2 quantification provides a useful clinical tool in evaluating cardiac pathology with acute cellular responses and edema. We hope with advances in spatial and temporal resolution T2 mapping can be used to determine myocardial viability in cases of AMI, predict transplant rejection, or help rule-out myocarditis.
